Morteza Naghavi, M.D. Founder Society for Heart Attack
Prevention and Eradication (SHAPE) SHAPE Guidelines Prevention of
Fatal Cardiovascular Events (Heart Attack & Stroke) based on
the Detection and Treatment of Subclinical Atherosclerosis (Hidden
Plaque Build-up in Coronary and Carotid arteries)
Slide 3
The Problem
Slide 4
> 15 Million Heart Attacks Each Year Source: World Heart
Federation The AEHA 2005 VP Summit
Slide 5
Unpredicted
Slide 6
In >50% of victims, the first symptom of asymptomatic
atherosclerosis is a sudden cardiac death or acute MI.
Slide 7
Men Women 010203040506070 Patients Diagnosed with CHD (%)
Murabito et al Circulation 1993 Sudden Cardiac Death or Acute MI as
Initial Presentation of CHD 62% 42%
Slide 8
Of 136,905 patients hospitalized with CAD, 77% had normal LDL
levels below 130 mg/dl Modified from Sachdeva et al. AHJ, Vol 157,
111-117 Jan 2009 Chapter 1: Preventive Cardiology; the SHAPE of the
Future in Naghavi et al. Asymptomatic Atherosclerosis:
Pathophysiology, Detection and Treatment. Humana Press, 2009
Slide 9
Modified from Sachdeva et al. AHJ, Vol 157, 111-117 Jan 2009
Chapter 1: Preventive Cardiology; the SHAPE of the Future in
Naghavi et al. Asymptomatic Atherosclerosis: Pathophysiology,
Detection and Treatment. Humana Press, 2009 Of 136,905 patients
hospitalized with CAD, 45.4% had normal HDL levels above 40
mg/dl
Slide 10
Of 136,905 patients hospitalized with CAD, 61.8% had normal
triglyceride levels below 150 mg/dl Modified from Sachdeva et al.
AHJ, Vol 157, 111-117 Jan 2009 Chapter 1: Preventive Cardiology;
the SHAPE of the Future in Naghavi et al. Asymptomatic
Atherosclerosis: Pathophysiology, Detection and Treatment. Humana
Press, 2009
Slide 11
Slide Source: Lipids Online www.lipidsonline.org 1998 2002. 222
patients with 1 st acute MI, no prior CAD, no DM. Men 20% Goal
LDL
Slide 12
Relying on risk factors of atherosclerosis (i.e. cholesterol
& blood pressure) mislead physicians and patients. A direct
assessment of atherosclerosis is needed. CONCLUSION:
Slide 13
Sir Winston Churchill, 91 Sir Winston Churchill, 91 Jim Fixx,
53 Jim Fixx, 53 Who Has More Cardiovascular Risk Factors?
Slide 14
Philip Alexander Poole-Wilson death with 66 years March 4, 2009
Two weeks after Update in Cardiology In Davos Helmut Drexler death
with 58 years Unexpected Sudden Death of Famous Cardiologists
Slide 15
Status Quo IS Unacceptable Bottom Line:
Slide 16
CVD Genotyping? Naghavi et al. Circulation. 2003;108:1664 ~50%
Apparently Healthy People (New) ~50% CHD Patients (Recurrent)
Slide 17
CVD Genotyping? Naghavi et al. Circulation. 2003;108:1664 ~50%
Apparently Healthy People (New) ~50% CHD Patients (Recurrent)
Slide 18
Naghavi et. al. Circulation Journal Vol108, No14; October 7,
2003 The Vulnerable Patient Consensus Statement Preceding the SHAPE
Initiative
Slide 19
Naghavi et. al. Circulation Journal Vol108, No14; October 7,
2003 The Vulnerable Patient Consensus Statement Preceding the SHAPE
Initiative
Slide 20
First SHAPE Symposium
Slide 21
SHAPE Task Force Meeting
Slide 22
SHAPE Guidelines Published
Slide 23
Slide 24
Existing Guidelines (Status Quo): Screen for Risk Factors of
Atherosclerosis Treat Risk Factors of Atherosclerosis The SHAPE
Guidelines: Screen for Atherosclerosis (the Disease) Regardless of
Risk Factors Treat based on the Severity of the Disease and its
Risk Factors SHAPE v.s. Status Quo
Slide 25
Slide 26
Slide 27
Based on the paper by Pepe e. al. Am J Epidemiol 2004;
159:882-890. ROC Curve, its AUC and Corresponding Odds Ratio hs-CRP
LDL HDL Smoking Hypertension Diabetes etc. Risk Factors
Slide 28
Slide 29
Based on the paper by Pepe e. al. Am J Epidemiol 2004;
159:882-890. ROC Curve, its AUC and Corresponding Odds Ratio hs-CRP
LDL HDL Smoking Hypertension Diabetes etc. CAC +FRS IMT+FRS
Structural Risk Factors
Slide 30
Slide 31
Based on the paper by Pepe e. al. Am J Epidemiol 2004;
159:882-890. ROC Curve, its AUC and Corresponding Odds Ratio hs-CRP
LDL HDL Smoking Hypertension Diabetes etc. CAC +FRS IMT+FRS
Structural Risk Factors Combined structural & functional?
Slide 32
Slide 33
Slide 34
1: No history of angina, heart attack, stroke, or peripheral
arterial disease. 2: Population over age 75y is considered high
risk and must receive therapy without testing for atherosclerosis.
3: Must not have any of the following: Chol>200 mg/dl, blood
pressure >120/80 mmHg, diabetes, smoking, family history,
metabolic syndrome. 4: Pending the development of standard practice
guidelines. 5: High cholesterol, high blood pressure, diabetes,
smoking, family history, metabolic syndrome. 6: For stroke
prevention, follow existing guidelines.
Slide 35
Some of the Members of the SHAPE Task Force (left to right):
Drs Budoff, Falk, Rumberger, Naghavi, Fayad, Hecht, and Berman
Slide 36
Current National Preventive Care Reimbursement Policies Do Not
Match the Burden of the Problem Inadequate &
Disproportionate
Slide 37
Slide 38
Why do we screen for asymptomatic cancers but ignore
asymptomatic CVD?
Slide 39
$1000 for # 2 Killer
Slide 40
Slide 41
Slide 42
Slide 43
Number (per year) Estimated Impact of SHAPE (Sensitivity
Analysis Range) Estimated Change in Cost CVD Deaths910,60010%
(5%-25%) ($1.2 b) MI (prevalence)7,200,000 25% (5%-35%) ($18.0 b)
Chest Pain Symptoms (ER visits)6,500,000 5% (2.5%-25%) ($4.1 b)
Hospital Discharge for Primary Diagnosis of CVD6,373,000 10%
(5%-25%) $3.8 b Hospital Discharge for Primary Diagnosis of
CHD970,000 10% (5%-25%) ($9.9 b) Cholesterol Lowering Therapy 50 %
(50%-65%) 8.00 b CV Imaging8,700,000 10% (5%-25%) $358 m
Angiography6,800,000 15% - CTA (2.5%-25%) $600 m PCI (percutaneous
coronary interventions per year)657,000 10% (5%-50%) ($580 m) CABS
(coronary artery bypass surgeries per year)515,000 5% (2.5%-50%)
($672 m) Total in Cost ($21.5 b) Cost Effectiveness of the SHAPE
Guidelines
Slide 44
Slide 45
poly pills
Slide 46
WWW.SHAPESOCIETY.ORG
Slide 47
The SHAPE Textbook Released at American College of Cardiology
Conference